Neuropharmacology News and Research

RSS

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Dr. Laura Ajram leads the British Neuroscience Association, focusing on enhancing neuroscience research through strategic partnerships and patient engagement.

2 Nov 2026

Cancer drug eliminates HIV-infected cells in animal model study

Emory University researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.

3 Sep 2026

Internet-controlled brain implant enables remote neural stimulation and drug delivery

A researcher in Chicago remotely controls a miniaturized brain implant in Daejeon, Korea - over the internet. Korean researchers have developed a wireless device that can deliver drugs and light to precisely modulate targeted neurons from anywhere in the world.

27 Aug 2026

Adolescents using nicotine face higher risks of mental health problems

Adolescents who use nicotine are more likely to report symptoms of anxiety, depression, and other mental health problems than their peers who do not use nicotine.

11 Aug 2026

Study reveals complex relationship between alcohol and Alzheimer's disease

Alcohol use has been associated with an increased risk of cognitive decline and dementia. But new research from the Texas A&M University Naresh K. Vashisht College of Medicine at Texas A&M Health suggests the relationship between alcohol and Alzheimer's disease is more complicated than previously thought.

9 Jul 2026

New peptide strategy may protect brain cells involved in Parkinson's disease

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered a new strategy that may protect neurons and other brain cells involved in Parkinson's disease in the future.

12 Jun 2026

Charting brain cell epigenomics to reveal origins of psychiatric disorders

In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple disciplines before arriving at fundamental questions about how the brain develops and what goes wrong in psychiatric disorders.

6 Jan 2026

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on psilocybin's effects on obsessive-compulsive behaviors, revealing consistent therapeutic potential across human patients and validated animal models.

29 Oct 2025

New insights into MDMA therapy for PTSD and beyond

A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr. Mingming Zhao and Dr. Jianjun Yang) synthesizes the evolving landscape of MDMA-assisted psychotherapy, examining robust clinical evidence in treatment-resistant posttraumatic stress disorder while identifying promising applications in autism spectrum disorder, eating disorders, and existential distress

14 Oct 2025

Targeting the cerebellum to ease alcohol withdrawal symptoms

By targeting a specific area of the brain, researchers at Washington State University may now hold the key to curbing the debilitating symptoms of alcohol withdrawal that push many people back to drinking.

30 Sep 2025

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Magic mushrooms may not be the answer to postpartum depression, new research from the University of California, Davis suggests.

30 Sep 2025

Prefrontal cortex biopsies during deep brain stimulation surgery do not increase risk of adverse events

Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that don't involve biopsies, a team of clinical research scientists at the Icahn School of Medicine at Mount Sinai has demonstrated.

4 Sep 2025

AXT brings Iconeus functional ultrasound to Australia and New Zealand, advancing brain research

AXT has partnered with Iconeus to distribute cutting-edge functional ultrasound (fUS) systems in Australia and New Zealand, enabling real-time, non-invasive imaging of brain activity and vasculature. The Iconeus One offers high-resolution vascular mapping and advanced neuroimaging capabilities for research.

From Iconeus 5 Aug 2025

Automated cage monitoring system reveals behavioral changes in schizophrenia mouse model

Schizophrenia is a serious mental health condition that affects thoughts, moods, perceptions, and behaviors.

24 Jul 2025

Unhealthy teen diets reshape the brain and drive lifelong eating habits, study finds

Adolescent diets high in fat and sugar disrupt the development of the prefrontal cortex and hippocampus, impacting cognition, memory, and impulse control. These brain changes can promote unhealthy eating behaviors and obesity risk that persist into adulthood.

24 Jun 2025

New molecular mechanism offers hope for causal epilepsy treatments

Epilepsy is primarily treated symptomatically - that is, the majority of the available medications aim to suppress seizures without influencing the underlying causes of the disease.

4 Jun 2025

GLP1 agonists linked to depression risk in new genetic study

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster drugs like Ozempic-and the risk of depression and suicidal ideation (SI).

17 Apr 2025

New drug class may help alleviate IBS symptoms by targeting the central nervous system

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, constipation, or both.

5 Feb 2025

Study identifies ophthalmic acid as an alternative to dopamine in motor control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.

4 Oct 2024

Study uncovers decision-making impairments linked to Parkinson's drug

Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of people worldwide.

24 Sep 2024

Neuropharmacology News and Research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Cancer drug eliminates HIV-infected cells in animal model study

Internet-controlled brain implant enables remote neural stimulation and drug delivery

Adolescents using nicotine face higher risks of mental health problems

Study reveals complex relationship between alcohol and Alzheimer's disease

New peptide strategy may protect brain cells involved in Parkinson's disease

Charting brain cell epigenomics to reveal origins of psychiatric disorders

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

New insights into MDMA therapy for PTSD and beyond

Targeting the cerebellum to ease alcohol withdrawal symptoms

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Prefrontal cortex biopsies during deep brain stimulation surgery do not increase risk of adverse events

AXT brings Iconeus functional ultrasound to Australia and New Zealand, advancing brain research

Automated cage monitoring system reveals behavioral changes in schizophrenia mouse model

Unhealthy teen diets reshape the brain and drive lifelong eating habits, study finds

New molecular mechanism offers hope for causal epilepsy treatments

GLP1 agonists linked to depression risk in new genetic study

New drug class may help alleviate IBS symptoms by targeting the central nervous system

Study identifies ophthalmic acid as an alternative to dopamine in motor control

Study uncovers decision-making impairments linked to Parkinson's drug

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News